Skip to content

Company information lookup

IMUGENE LIMITED (IMU)

An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IMU 0.011 0% 0.010 0.012 0.012 0.012 0.011 145,772

IMUGENE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IMU
Securities
Official Listing Date 24 November, 1993
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.imugene.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3142
Head Office Telephone 03 9824 5254
Head Office Fax 03 9822 7735
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Paul Hopper (Executive Chairman, Non Exec. Director)
Dr Nicholas Ede (Executive Director)
Dr Axel Hoos (Non Exec. Director)
Mr Phillip Hains (CFO)
Company Secretary Mr Justyn Stedwell
Mr Phillip Hains (Joint Co. Secretary)
Principal Activities An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

IMUGENE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/04/2014   Change of Director's Interest Notice (NE) 2 PDF
24/03/2014 asterix Imugene Allowed Israel Patent for Cancer Vaccine 1 PDF
17/03/2014 asterix IMU Commences FDA IND Process for Gastric Cancer vaccine 2 PDF
27/02/2014 asterix Half Yearly Report and Accounts 23 PDF
25/02/2014   Imugene Investor Update 6 PDF
29/01/2014 asterix Appendix 4C - quarterly 5 PDF
20/01/2014   Scientific Advisory Board Appointments 1 PDF
24/12/2013   Change of Director's Interest Notice 2 PDF
24/12/2013   Becoming a substantial holder 2 PDF
24/12/2013   Initial Director's Interest Notice 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
15 Apr 2014 0.011 10% 0.011 0.011 50,000
11 Apr 2014 0.010 -9.09% 0.011 0.010 357,228
10 Apr 2014 0.011 0% 0.012 0.011 800,667
09 Apr 2014 0.011 0% 0.011 0.011 16,629
08 Apr 2014 0.011 0% 0.011 0.011 283,371

* Volume of shares shown represents only those shares traded on ASX.

IMUGENE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IMU

Warrants & Structured Products

No warrants & Structured Products are available over the security IMU

ASX CFDs

No Contracts For Differences are available over the security IMU